KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $222,000 | +3.3% | 1,235 | -40.3% | 0.41% | -0.5% |
| Q2 2017 | $215,000 | +32.7% | 2,070 | 0.0% | 0.41% | +24.4% |
| Q1 2017 | $162,000 | +74.2% | 2,070 | 0.0% | 0.33% | +66.5% |
| Q4 2016 | $93,000 | -99.9% | 2,070 | 0.0% | 0.20% | +21.6% |
| Q3 2016 | $115,630,000 | +111082.7% | 2,070 | 0.0% | 0.16% | +90.6% |
| Q2 2016 | $104,000 | -99.9% | 2,070 | -33.9% | 0.08% | -6.6% |
| Q1 2016 | $143,698,000 | +74354.9% | 3,130 | 0.0% | 0.09% | -22.2% |
| Q4 2015 | $193,000 | +7.8% | 3,130 | -2.5% | 0.12% | -7.1% |
| Q3 2015 | $179,000 | – | 3,210 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |